Switzerland Tech Review
SEE OTHER BRANDS

Get your fresh news on science and technology in Switzerland

Switzerland Tech Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Switzerland Tech Review.

Press releases published on July 29, 2025

Robb Report Names Matchmaker For Private Jet Programs Private Jet Card Comparisons' Doug Gollan To ‘Masters Of Luxury’

Robb Report Names Matchmaker For Private Jet Programs Private Jet Card Comparisons' Doug Gollan To ‘Masters Of Luxury’

Luxury lifestyle magazine Robb Report has named the founder and editor of Private Jet Card Comparisons, Doug Gollan, to its 'Masters of Luxury' for aviation. MIAMI, FL, UNITED STATES, July 29, 2025 /⁨EINPresswire.com⁩/ -- The founder and principal of a …

Fuelled by an Oversubscribed Seed Round, pRxEngage Aims to Make Clinical Trials a Real Option for All

Fuelled by an Oversubscribed Seed Round, pRxEngage Aims to Make Clinical Trials a Real Option for All

With 30K+ users in the past month alone, pRxEngage is turning discovery into action, making clinical trial access smarter, more personal, and more human. ATLANTA , GA, UNITED STATES, July 29, 2025 /⁨EINPresswire.com⁩/ -- In less than three months from …

Basilea initiiert Phase-3-Studie mit Antipilzmittel Fosmanogepix bei invasiven Schimmelpilzinfektionen

Basilea initiiert Phase-3-Studie mit Antipilzmittel Fosmanogepix bei invasiven Schimmelpilzinfektionen

Studie zur Evaluierung der Wirksamkeit und Sicherheit von Fosmanogepix bei Erwachsenen mit invasiven Schimmelpilzinfektionen Studienabschluss im 1. Quartal 2028 erwartet Allschwil, 29. Juli 2025 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein …

Basilea initiates phase 3 study with antifungal fosmanogepix in invasive mold infections

Basilea initiates phase 3 study with antifungal fosmanogepix in invasive mold infections

Study to evaluate the efficacy and safety of fosmanogepix in adults with invasive mold infections Study completion expected in Q1 2028 Allschwil, Switzerland, July 29, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions